Abstract
With our interest in (S)-3-aminopyrrolidine derivatives, we further screened inhibition activities of three hit compounds on many other kinases with the results demonstrating that this series of compounds shows better anticancer activities, which might result from the main block of PI3K/Akt signaling pathway and the inhibition of Abelson murine leukemia viral oncogene homolog(ABL) kinase, as well as some epidermal growth factors. Further structure modification demonstrates that benzylsulfonyl group is the necessary functional group contributing to the biological activity that will be helpful to guiding us to optimize these (S)-3-aminopyrrolidine derivatives.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Druker B. J., Talpaz M., Resta D. J., Peng B., Buchdunger E., Ford J. M., Lydon N. B., Kantarjian H., Capdeville R., Ohno-Jones S., Sawyers C. L., N. Engl. J. Med., 2001, 344, 1031
Liao J. J. L., J. Med. Chem., 2007, 50, 409
Morphy R., J. Med. Chem., 2010, 53, 1413
Golas J. M., Arndt K., Etienne C., Lucas J., Nardin D., Gibbons J., Frost P., Ye F., Boschelli D. H., Boschelli F., Cancer Res., 2003, 63, 375
Kimura S., Naito H., Segawa H., Kuroda J., Yuasa T., Sato K., Yokota A., Kamitsuji Y., Kawata E., Ashihara E., Nakaya Y., Naruoka H., Wakayama T., Nasu K., Asaki T., Niwa T., Hirabayashi K., Maekawa T., Blood, 2005, 106, 3948
Lockton J. A., Smethurst D., Macpherson M., Tootell R., Marshall A. L., Clack G., Gallagher N. J., J. Clin. Oncol., 2005, 23, 223s
Daub H., Specht K., Ullrich A., Nat. Rev. Drug Discovery, 2004, 3, 1001
Shah N. P., Nicoll J. M., Nagar B., Gorre M. E., Paquette R. L., Kuriyan J., Sawyers C. L., Cancer Cell, 2002, 2, 117
Weisberg E., Griffin J. D., Drug Resist. Updates, 2001, 4, 22
Weisberg E., Griffin J. D., Blood, 2000, 95, 3498
Engelman J. A., Zejnullahu K., Mitsudomi T., Song Y. C., Hyland C., Park J. O., Lindeman N., Gale C. M., Zhao X. J., Christensen J., Kosaka T., Holmes A. J., Rogers A. M., Cappuzzo F., Mok T., Lee C., Johnson B. E., Cantley L. C., Janne P. A., Science, 2007, 316, 1039
Huo X., Zhang Q., Liu Y., Chem. Res. Chinese Universities, 2010, 26(3), 409
Burchert A., Wang Y., Cai D., Bubnoff N. V., Paschka P., Muller-Brusselbach S., Ottmann O. G., Duyster J., Hochhaus A., Neubauer A., Leukemia, 2005, 19, 1774
Apsel B., Blair J. A., Gonzalez B., Nazif T. M., Feldman M. E., Aizenstein B., Hoffman R., Williams R. L., Shokat K. M., Knight Z. A., Nat. Chem. Biol., 2008, 4, 691
Peng H., Huang N., Qi J., Xie P., Xu C., Wang J. X., Yang C. Z., Bioorg. Med. Chem. Lett., 2003, 13, 3693
Zhang C. L., Tan C. Y., Zu X. Y., Zhai X., Liu F., Chu B. Z., Ma X. H., Chen Y. Z., Gong P., Jiang Y. Y., Eur. J. Med. Chem., 2011, 46, 1404
Yano S., Nishioka Y., Goto H., Sone S., Assay Drug Dev. Technol., 2007, 5, 75
Konecny G. E., Pegram M. D., Venkatesan N., Finn R., Yang G. R., Rahmeh M., Untch M., Rusnak D. W., Spehar G., Mullin R. J., Keith B. R., Gilmer T. M., Berger M., Podratz K. C., Slamon D. J., Cancer Sci., 2003, 94, 479
Liu H. C., Dong A. J., Gao C. M., Tan C. Y., Liu H. X., Zu X. Y., Jiang Y. Y., Cancer Res., 2006, 66, 1630
Baki A., Bielik A., Molnar L., Szendrei G., Keseru G. M., Bioorg. Med. Chem., 2008, 16, 100
Author information
Authors and Affiliations
Corresponding authors
Additional information
Supported by the Ministry of Science and Technology of China(Nos.2012ZX09506001-010, 2012CB722605).
Rights and permissions
About this article
Cite this article
Xin, T., Zhang, C., Tan, C. et al. Biological evaluation and structure modification of (S)-3-aminopyrrolidine derivatives. Chem. Res. Chin. Univ. 30, 91–97 (2014). https://doi.org/10.1007/s40242-014-3174-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40242-014-3174-3